Vaxart, Inc. Debt Securities, Held-to-maturity, Fair Value
Vaxart, Inc. (VXRT) had Debt Securities, Held-to-maturity, Fair Value of $15.00 thousand as of 2018-12-31, per its 10-K filed 2019-02-06.
Discontinued › Balance Sheet › Assets
us-gaap:HeldToMaturitySecuritiesFairValue · last filed 2019-02-06
- 2018-12-31: Debt Securities, Held-to-maturity, Fair Value $15.00K.
- 2018-09-30: Debt Securities, Held-to-maturity, Fair Value $14.00K.
- 2018-06-30: Debt Securities, Held-to-maturity, Fair Value $13.00K.
- 2018-03-31: Debt Securities, Held-to-maturity, Fair Value $5.60M.
| Period end | Debt Securities, Held-to-maturity, Fair Value |
|---|---|
| 2018-12-31 | $15.00K 10-K · filed 2019-02-06 |
| 2018-09-30 | $14.00K 10-Q · filed 2018-11-13 |
| 2018-06-30 | $13.00K 10-Q · filed 2018-08-10 |
| 2018-03-31 | $5.60M 10-Q · filed 2018-05-15 |
| 2017-12-31 | $2.61M 10-K · filed 2019-02-06 |
| 2017-03-31 | $2.61M 10-Q · filed 2018-05-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Kalaris Therapeutics, Inc. (KLRS) | United States | $0.073B | -2.19 |
| Atara Biotherapeutics, Inc. (ATRA) | United States | $0.086B | -6.48 |
| Pelthos Therapeutics Inc. (PTHS) | United States | $0.086B | -1.20 |
| CHAMPIONS ONCOLOGY, INC. (CSBR) | United States | $0.070B | -68.02 |
| COGNITION THERAPEUTICS INC (CGTX) | United States | $0.090B | -6.52 |
| BioStem Technologies, Inc. (BSEM) | United States | $0.069B | |
| Eloxx Pharmaceuticals, Inc. (ELOX) | United States | $0.065B | |
| MiNK Therapeutics, Inc. (INKT) | United States | $0.063B | -5.37 |
| Cardiff Oncology, Inc. (CRDF) | United States | $0.101B | -2.22 |
| EXOZYMES INC. (EXOZ) | United States | $0.058B |